微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 33.81% | -50.9% | -2.53% | 46/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 34.69% | -48.08% | -46.13% | 47/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 64.38% | -10.01% | 2.72% | 33/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 62.68% | -10.15% | -8.96% | 35/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 68.85% | -3.01% | 3.06% | 31/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 66.81% | -6.14% | -6.61% | 33/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 71.54% | 4.75% | 2.56% | 27/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 69.76% | -1.79% | -1.73% | 32/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 70.99% | 0.71% | -0.28% | 31/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 71.19% | 2.12% | 4.22% | 32/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 68.3% | -7.38% | -3.85% | 32/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 71.04% | 2.33% | 0.78% | 29/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 70.49% | -8.38% | 1.12% | 30/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 69.71% | -8.23% | -5.47% | 31/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 73.74% | -0.32% | 6.23% | 29/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 69.42% | 19.96% | -9.77% | 33/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 76.93% | 20.21% | 1.28% | 31/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 75.96% | 27.96% | 2.67% | 33/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 73.98% | 53.51% | 27.85% | 26/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 57.87% | -22.24% | -9.58% | 35/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 64% | -13.33% | 7.81% | 26/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 59.36% | -18.89% | 23.17% | 34/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 48.19% | -39.23% | -35.24% | 25/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 74.42% | -0.95% | 0.77% | 28/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 73.85% | -2.11% | 0.9% | 18/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 73.19% | -3.29% | -7.7% | 17/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 79.3% | -2.92% | 5.55% | 13/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 75.13% | -1.22% | -0.41% | 24/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 75.44% | 9.81% | -0.32% | 13/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 75.68% | 15.07% | -7.35% | 13/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 81.69% | 28.44% | 7.4% | 8/55 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 76.06% | 16.26% | 10.72% | 19/55 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 68.7% | 6.21% | 4.45% | 11/55 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 65.77% | 5.37% | 3.42% | 14/55 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 63.6% | 0.92% | -2.79% | 14/55 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 65.42% | 5.26% | 1.14% | 17/55 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 64.68% | 3.17% | 3.63% | 11/55 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 62.42% | -1.1% | -0.95% | 15/55 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 63.02% | -1.27% | 1.39% | 12/55 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 62.15% | 4.84% | -0.86% | 16/55 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 62.69% | 7.62% | -0.67% | 9/55 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 63.11% | 8.09% | -1.12% | 11/55 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 63.83% | -1.98% | 7.66% | 8/55 | 57.69% | 我武生物 | 95.59% | 行业排名> |